Mark Blumenkranz
Director/Board Member at KALA BIO, INC.
Net worth: 51 351 $ as of 2024-03-30
Profile
Mark S.
Blumenkranz, M.D., MMS, is HJ Smead Professor in the Department of Ophthalmology at Stanford University.
He received his Undergraduate, Masters degree in biochemical pharmacology, and MD at Brown, Ophthalmic residency training at Stanford, and a Fellowship in vitreo-retinal diseases at the Bascom Palmer Eye Institute.
?
He was a director of Oculex Pharmaceuticals, a privately held pharmaceutical company that pioneered the use of bio-erodable polymers for extended release of ocular steroids.
At Oculex he was also Chairman of the SAB and the principal designer of the successful phase 2 Ozurdex trial, leading to its acquisition by Allergan in 2003.
He served as a co-founder, Director and Chairman of the SAB of Macusight, an ophthalmic pharmaceutical company developing proprietary mTor inhibitors for ophthalmic disease, which was acquired by Santen in 2010.
He was a founder and director of Peak Surgical, an innovator in pulsed plasma mediated electro-surgery that was acquired by Medtronics in 2011.
In 2004 he co-founded Optimedica Corporation for which he co-wrote the foundation IP for the PASCAL and Catalys lasers, and which was acquired by AMO in 2013.
In 2006 co-founded Adverum Biotechnologies (ADVM; NASDAQ) a gene therapy company and served as Chairman of the Board until 2016.
He was a co-founder and director of Oculeve, a dry eye company employing a neuro-modulatory approach to therapy, which was acquired by Allergan in August of 2015.
He is a co-founder and serves as a director of Digisight Corporation, a venture financed ophthalmic digital health company and Lagunita Biosciences LLC an early stage biotechnology and medical investment company.
?
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
KALA BIO, INC.
0.24% | 2023-06-21 | 6,443 ( 0.24% ) | 51 351 $ | 2024-03-30 |
Mark Blumenkranz active positions
| Companies | Position | Start |
|---|---|---|
| KALA BIO, INC. | Director/Board Member | 2021-11-14 |
| Oculogics, Inc. | Director/Board Member | - |
Lagunita Biosciences LLC
 Lagunita Biosciences LLC Investment ManagersFinance Lagunita Biosciences LLC (Lagunita Biosciences) is a venture Capital firm founded in 2015 by Mark S. Blumenkranz. The firm is headquartered in Menlo Park, California. | Founder | 2015-09-30 |
BVI Holdings Ltd.
 BVI Holdings Ltd. Financial ConglomeratesFinance BVI Holdings Ltd. operates as an investment holding company. The company was founded on December 13, 2018 and is headquartered in Abingdon, the United Kingdom. | Director/Board Member | 2019-02-26 |
Beaver-Visitec International, Inc.
 Beaver-Visitec International, Inc. Medical SpecialtiesHealth Technology Beaver-Visitec International, Inc. develops and manufactures products for ophthalmic and specialty microsurgical procedures. Its products include I-Ring pupil expander, knives and blades, electrosurgery, forceps, manipulators, specula, scissors, needle holders, diagnostic lights, and punctal occlusion. The firm offers following brands: Atomic Edge, Beaver, Maxi-Lite, Blu-Spot, Blu-Slit, C-Line, Ocutek, CustomEyes, OcuSeal, MultiVisc, Visc, Aqueo Premium, Merocel, Keracel, Weck-Cel, Visitec, Wet-Field, Accu-Temp, Endo Optiks, and Odyssey. The company was founded on July 29, 1965 and is headquartered in Waltham, MA. | Director/Board Member | - |
| Stanford University | Corporate Officer/Principal | 1996-12-31 |
| Combangio Corp. | Director/Board Member | - |
BVI Medical, Inc.
 BVI Medical, Inc. Medical SpecialtiesHealth Technology BVI Medical, Inc. is a private company based in Waltham, MA. BVI Medical, Inc. was founded in 2010. Shervin Joe Korangy has been the CEO of the company since 2017. | Director/Board Member | - |
Silicom Ventures LLC
 Silicom Ventures LLC Investment ManagersFinance Silicom Ventures LLC (Silicom Ventures) is a venture capital firm founded in 2000 by Gadi Behar. The firm is headquartered in Los Altos, California. | Consultant / Advisor | - |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Former positions of Mark Blumenkranz
| Companies | Position | End |
|---|---|---|
| ░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░ | - |
| ░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ |
Training of Mark Blumenkranz
| Brown University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| KALA BIO, INC. | Health Technology |
| ADVERUM BIOTECHNOLOGIES, INC. | Health Technology |
| PRESBIA PLC | Health Technology |
| Private companies | 29 |
|---|---|
Ophthalmic Imaging Systems, Inc.
 Ophthalmic Imaging Systems, Inc. Medical SpecialtiesHealth Technology Ophthalmic Imaging Systems, Inc. manufactures ophthalmic digital imaging systems. Its principal activity is to design, develop, manufacture and market digital imaging system, image enhancement and analysis software and related products and services used by the practitioners in the ocular healthcare field. The current flagship product in the Group's angiography line is its digital imaging systems. Its products include WinStation systems, Digital Fundus Imager, Digital Slit Lamp Imager and Slit Lamps. Retina specialists and general ophthalmologists use the WinStation systems. The company was founded on July 14, 1986 and is headquartered in Sacramento, CA. | Health Technology |
Oldtech, Inc.
 Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Health Technology |
MacuSight, Inc.
 MacuSight, Inc. Pharmaceuticals: MajorHealth Technology MacuSight, Inc. develops and manufactures pharmaceuticals products. The firm engages in developing therapeutics for the treatment of severe ocular diseases and conditions. It offers sirolimus, a therapeutic for the treatment and prevention of wet age-related macular degeneration, as well as for the treatment of diabetic macular edema; and related compounds and other select therapeutics in the eye, as well as minimally-invasive ocular formulations. The company was founded in 2003 and is headquartered in Union City, CA. | Health Technology |
OptiMedica Corp.
 OptiMedica Corp. Medical SpecialtiesHealth Technology OptiMedica Corp. manufactures medical devices. It is a ophthalmic device company dedicated to developing technologies that improve patient outcomes. It focuses in the cataract therapeutic area. The company was founded in 2004 and is headquartered in Sunnyvale, CA. | Health Technology |
PEAK Surgical, Inc.
 PEAK Surgical, Inc. Medical SpecialtiesHealth Technology PEAK Surgical is a medical device company that has developed the PEAK Surgery System, a new tissue dissection system based on a proprietary technology that represents an important advance in radiofrequency surgical technologies. The PEAK Surgery System consists of the PEAK PlasmaBlade, a family of disposable cutting devices that offer the exacting control of a scalpel and the bleeding control of traditional electrosurgery without extensive collateral damage, and the PULSAR Generator, which supplies pulsed plasma radiofrequency energy to the PlasmaBlade. The PEAK Surgery System is cleared for use in general, plastic and reconstructive, ENT, gynecologic, orthopedic, arthroscopic, spinal and neurological surgical procedures in the United States, and for use in general surgery in the European Union. It was launched in the United States in July 2008 and has been used by U.S. surgeons on many patients, including general, gynecologic, orthopedic and plastic and reconstructive surgeries | Health Technology |
1Life Healthcare, Inc.
 1Life Healthcare, Inc. Medical/Nursing ServicesHealth Services 1Life Healthcare, Inc. engages in the provision of healthcare membership services. It offers walk-in immunizations and lab services, behavioral health, women's health, men’s health, LGBTQ+ care, pediatrics, sports medicine, lifestyle, and wellbeing programs. The company was founded by Thomas H. Lee on July 25, 2002 and is headquartered in San Francisco, CA. | Health Services |
Oculeve, Inc.
 Oculeve, Inc. Medical SpecialtiesHealth Technology Oculeve, Inc. develops devices for dry eye disease treatment. The company was founded by D. Michael Ackermann, Brandon M. Felkins, Garrett Cale Smith and Victor Wayne McCray in 2011 and is headquartered in Parsippany, NJ. | Health Technology |
Oculex Pharmaceuticals, Inc.
 Oculex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Oculex Pharmaceuticals, Inc. manufactures and develops drugs. The company focuses on developing and manufacturing novel drug delivery systems that resolve the problems associated with treatment of inflammation following cataract surgery and diseases of the eye. It is located in Sunnyvale, CA. | Health Technology |
Silicom Ventures LLC
Silicom Ventures LLC Investment ManagersFinance Silicom Ventures LLC (Silicom Ventures) is a venture capital firm founded in 2000 by Gadi Behar. The firm is headquartered in Los Altos, California. | Finance |
| Association of University Professors of Ophthalmology | |
| Macula Society | |
IVERIC bio, Inc.
 IVERIC bio, Inc. Pharmaceuticals: GenericHealth Technology IVERIC bio, Inc. operates as a biopharmaceutical company. The firm engages in discovering, developing and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in Parsippany, NJ. | Health Technology |
| The Retina Society | |
| Midlab, Inc. | |
Beaver-Visitec International, Inc.
Beaver-Visitec International, Inc. Medical SpecialtiesHealth Technology Beaver-Visitec International, Inc. develops and manufactures products for ophthalmic and specialty microsurgical procedures. Its products include I-Ring pupil expander, knives and blades, electrosurgery, forceps, manipulators, specula, scissors, needle holders, diagnostic lights, and punctal occlusion. The firm offers following brands: Atomic Edge, Beaver, Maxi-Lite, Blu-Spot, Blu-Slit, C-Line, Ocutek, CustomEyes, OcuSeal, MultiVisc, Visc, Aqueo Premium, Merocel, Keracel, Weck-Cel, Visitec, Wet-Field, Accu-Temp, Endo Optiks, and Odyssey. The company was founded on July 29, 1965 and is headquartered in Waltham, MA. | Health Technology |
Presbia Holdings LLC
 Presbia Holdings LLC Miscellaneous Commercial ServicesCommercial Services Presbia Holdings LLC operates as a medical device firm. The company is headquartered in Los Angeles, CA. | Commercial Services |
| Byers Eye Institute | |
Presbia USA, Inc.
 Presbia USA, Inc. Medical SpecialtiesHealth Technology Part of Presbia PLC, Presbia USA, Inc. is a medical device manufacturer. The CEO of the American company is Zohar Loshitzer. | Health Technology |
Vantage Surgical Systems, Inc.
 Vantage Surgical Systems, Inc. Medical SpecialtiesHealth Technology Vantage Surgical Systems, Inc. develops medical imaging systems for minimally invasive procedures. The private company is based in Los Angeles, CA. The CEO of the company is Zohar Loshitzer. | Health Technology |
Verana Health, Inc.
 Verana Health, Inc. Packaged SoftwareTechnology Services Verana Health, Inc. engages in the development of software solutions for remote patient monitoring and data analytics. It focuses on bridging the gap between healthcare providers and patients with mobile tests. The company was founded by Mark S. Blumenkranz and Daniel V. Palanker in 2008 and is headquartered in San Francisco, CA. | Technology Services |
| Oculogics, Inc. | |
Viewpoint Therapeutics, Inc.
 Viewpoint Therapeutics, Inc. BiotechnologyHealth Technology Viewpoint Therapeutics, Inc. operates as a biotechnology company. It prevents and treats cataracts and presbyopia, and protein misfolding. The company was founded by Leah Makley in July of 2014 and is headquartered in San Francisco, CA. | Health Technology |
Lagunita Biosciences LLC
Lagunita Biosciences LLC Investment ManagersFinance Lagunita Biosciences LLC (Lagunita Biosciences) is a venture Capital firm founded in 2015 by Mark S. Blumenkranz. The firm is headquartered in Menlo Park, California. | Finance |
Kedalion Therapeutics, Inc.
 Kedalion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kedalion Therapeutics, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of topical ophthalmology therapies based on its proprietary AcuStream platform. The company was founded by Mark Blumenkranz and Ehud Ivri and is headquartered in Menlo Park, CA. | Health Technology |
BVI Medical, Inc.
BVI Medical, Inc. Medical SpecialtiesHealth Technology BVI Medical, Inc. is a private company based in Waltham, MA. BVI Medical, Inc. was founded in 2010. Shervin Joe Korangy has been the CEO of the company since 2017. | Health Technology |
| Retinal Degeneration Fund | |
BVI Holdings Ltd.
BVI Holdings Ltd. Financial ConglomeratesFinance BVI Holdings Ltd. operates as an investment holding company. The company was founded on December 13, 2018 and is headquartered in Abingdon, the United Kingdom. | Finance |
Combangio, Inc.
 Combangio, Inc. Miscellaneous Commercial ServicesCommercial Services Combangio, Inc. operates as an investment holding company. The company was headquartered in Menlo Park, CA. | Commercial Services |
| Combangio Corp. |
- Stock Market
- Insiders
- Mark Blumenkranz
